-
1
-
-
4444382796
-
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
-
Yusuf S, Hawken S, Ounpuu S, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364(9438):937-952
-
(2004)
Lancet
, vol.364
, Issue.9438
, pp. 937-952
-
-
Yusuf, S.1
Hawken, S.2
Ounpuu, S.3
-
2
-
-
2942519743
-
Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)
-
Rothwell PM, Coull AJ, Giles MF, et al. (2004) Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363(9425):1925-1933
-
(2004)
Lancet
, vol.363
, Issue.9425
, pp. 1925-1933
-
-
Rothwell, P.M.1
Coull, A.J.2
Giles, M.F.3
-
3
-
-
0027380992
-
Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials
-
Atkins D, Psaty BM, Koepsell TD, et al. (1993) Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med 119(2):136-145
-
(1993)
Ann Intern Med
, vol.119
, Issue.2
, pp. 136-145
-
-
Atkins, D.1
Psaty, B.M.2
Koepsell, T.D.3
-
4
-
-
0023276691
-
Compensatory enlargement of human atherosclerotic coronary arteries
-
Glagov S, Weisenberg E, Zarins CK, et al. (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316(22):1371-1375
-
(1987)
N Engl J Med
, vol.316
, Issue.22
, pp. 1371-1375
-
-
Glagov, S.1
Weisenberg, E.2
Zarins, C.K.3
-
5
-
-
0031647047
-
Coronary artery remodelling and the assessment of stenosis by pathologists
-
Davies MJ (1998) Coronary artery remodelling and the assessment of stenosis by pathologists. Histopathology 33(6):497-500
-
(1998)
Histopathology
, vol.33
, Issue.6
, pp. 497-500
-
-
Davies, M.J.1
-
6
-
-
0029090411
-
Coronary plaque disruption
-
Falk E, Shah PK, Fuster V (1995) Coronary plaque disruption. Circulation 92(3):657-671
-
(1995)
Circulation
, vol.92
, Issue.3
, pp. 657-671
-
-
Falk, E.1
Shah, P.K.2
Fuster, V.3
-
7
-
-
27544472697
-
Carotid intimalmedia thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
-
Espeland MA, O'Leary DH, Terry JG, et al. (2005) Carotid intimalmedia thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 6(1):3
-
(2005)
Curr Control Trials Cardiovasc Med
, vol.6
, Issue.1
, pp. 3
-
-
Espeland, M.A.1
O'Leary, D.H.2
Terry, J.G.3
-
8
-
-
0037148894
-
Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease
-
Spence JD (2002) Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol 89(4A):10B-15B
-
(2002)
Am J Cardiol 89(4A)
-
-
Spence, J.D.1
-
9
-
-
0037148917
-
Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis
-
Nissen SE (2002) Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. Am J Cardiol 89(4A):24B-31B
-
(2002)
Am J Cardiol 89(4A)
-
-
Nissen, S.E.1
-
10
-
-
0029598777
-
Acute coronary thrombosis: The role of plaque disruption and its initiation and prevention
-
Davies MJ (1995) Acute coronary thrombosis: The role of plaque disruption and its initiation and prevention. Eur Heart J 16( Suppl L):3-7
-
(1995)
Eur Heart J
, vol.16
, Issue.SUPPL. L
, pp. 3-7
-
-
Davies, M.J.1
-
11
-
-
0021164827
-
The seven countries study: 2,289 deaths in 15 years
-
Keys A, Menotti A, Aravanis C, et al. (1984) The seven countries study: 2,289 deaths in 15 years. Prev Med 13(2):141-154
-
(1984)
Prev Med
, vol.13
, Issue.2
, pp. 141-154
-
-
Keys, A.1
Menotti, A.2
Aravanis, C.3
-
12
-
-
84911661493
-
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group
-
Buchwald H, Matts JP, Fitch LL, et al. (1992) Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group. JAMA 1268(11):1429-1433
-
(1992)
JAMA
, vol.1268
, Issue.11
, pp. 1429-1433
-
-
Buchwald, H.1
Matts, J.P.2
Fitch, L.L.3
-
13
-
-
0026582213
-
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
-
Watts GF, Lewis B, Brunt JN, et al. (1992) Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339(8793):563-569
-
(1992)
Lancet
, vol.339
, Issue.8793
, pp. 563-569
-
-
Watts, G.F.1
Lewis, B.2
Brunt, J.N.3
-
14
-
-
0032926503
-
Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study. The Care Investigators
-
Plehn JF, Davis BR, Sacks FM, et al. (1999) Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 99(2):216-223
-
(1999)
Circulation
, vol.99
, Issue.2
, pp. 216-223
-
-
Plehn, J.F.1
Davis, B.R.2
Sacks, F.M.3
-
15
-
-
0035936503
-
Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project
-
Byington RP, Davis BR, Plehn JF, et al. (2001) Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project. Circulation 103(3):387-392
-
(2001)
Circulation
, vol.103
, Issue.3
, pp. 387-392
-
-
Byington, R.P.1
Davis, B.R.2
Plehn, J.F.3
-
16
-
-
0028845911
-
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
-
Byington RP, Jukema JW, Salonen JT, et al. (1995) Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 92(9):2419-2425
-
(1995)
Circulation
, vol.92
, Issue.9
, pp. 2419-2425
-
-
Byington, R.P.1
Jukema, J.W.2
Salonen, J.T.3
-
17
-
-
0036023515
-
Treatment with Atorvastatin to the National Cholesterol Educational Program Goals versus Usual Care in Secondary Coronary Heart Disease Prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
-
Athyros VG, Papageorgiou AA, Mercouris BR, et al. (2002) Treatment with Atorvastatin to the National Cholesterol Educational Program Goals versus Usual Care in Secondary Coronary Heart Disease Prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Curr Med Res Opin 18(4): 220-228
-
(2002)
Curr Med Res Opin
, vol.18
, Issue.4
, pp. 220-228
-
-
Athyros, V.G.1
Papageorgiou, A.A.2
Mercouris, B.R.3
-
18
-
-
0032966298
-
Systematic review on the risk and benefit of different cholesterol-lowering interventions
-
Bucher HC, Griffith LE, Guyatt GH (1999) Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol 19(2):187-195
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, Issue.2
, pp. 187-195
-
-
Bucher, H.C.1
Griffith, L.E.2
Guyatt, G.H.3
-
19
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
Baigent C, Keech A, Kearney PM, et al. (2005) Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267-1278
-
(2005)
Lancet
, vol.366
, Issue.9493
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
-
20
-
-
21344475107
-
The changing face of cardiovascular risk
-
Grundy SM (2005) The changing face of cardiovascular risk. J Am Coll Cardiol 46(1):173-175
-
(2005)
J Am Coll Cardiol
, vol.46
, Issue.1
, pp. 173-175
-
-
Grundy, S.M.1
-
21
-
-
0029102150
-
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)
-
Byington RP, Furberg CD, Crouse JR, III, et al. (1995) Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol 76(9):54C-59C
-
(1995)
Am J Cardiol
, vol.76
, Issue.9
-
-
Byington, R.P.1
Furberg, C.D.2
Crouse III, J.R.3
-
22
-
-
0029096765
-
Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
-
Salonen R, Nyyssonen K, Porkkala E, et al. (1995) Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 92(7):1758-1764
-
(1995)
Circulation
, vol.92
, Issue.7
, pp. 1758-1764
-
-
Salonen, R.1
Nyyssonen, K.2
Porkkala, E.3
-
23
-
-
10744225301
-
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial
-
Nissen SE, Tuzcu EM, Schoenhagen P, et al. (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 291(9):1071-1080
-
(2004)
JAMA
, vol.291
, Issue.9
, pp. 1071-1080
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Schoenhagen, P.3
-
24
-
-
33645524176
-
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial
-
Nissen SE, Nicholls SJ, Sipahi I, et al. (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 295(13):1556-1565
-
(2006)
JAMA
, vol.295
, Issue.13
, pp. 1556-1565
-
-
Nissen, S.E.1
Nicholls, S.J.2
Sipahi, I.3
-
25
-
-
3042755369
-
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S)
-
Pyorala K, Ballantyne CM, Gumbiner B, et al. (2004) Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 27(7):1735-1740
-
(2004)
Diabetes Care
, vol.27
, Issue.7
, pp. 1735-1740
-
-
Pyorala, K.1
Ballantyne, C.M.2
Gumbiner, B.3
-
26
-
-
1542345696
-
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions
-
Collins R, Armitage J, Parish S, et al. (2004) Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363(9411):757-767
-
(2004)
Lancet
, vol.363
, Issue.9411
, pp. 757-767
-
-
Collins, R.1
Armitage, J.2
Parish, S.3
-
27
-
-
0344541709
-
Statin-sensitive dys-regulated AT1 receptor function and density in hypercholesterolemic men
-
Nickenig G, Baumer AT, Temur Y, et al. (1999) Statin-sensitive dys-regulated AT1 receptor function and density in hypercholesterolemic men. Circulation 100(21):2131-2134
-
(1999)
Circulation
, vol.100
, Issue.21
, pp. 2131-2134
-
-
Nickenig, G.1
Baumer, A.T.2
Temur, Y.3
-
28
-
-
5444258666
-
Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease
-
Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. (2004) Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease. J Hum Hypertens 18(11):781-788
-
(2004)
J Hum Hypertens
, vol.18
, Issue.11
, pp. 781-788
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Papageorgiou, A.A.3
-
29
-
-
33846451669
-
-
Poulter N, Sever PS (2004) Do statins lower blood pressure? Evidence from the Anglo-Scandinavian Cardiac Outcomes Trial- Lipid-Lowering Arm (ASCOT-LLA). Circulation 110(Suppl III):III-402(abstract 1905)
-
Poulter N, Sever PS (2004) Do statins lower blood pressure? Evidence from the Anglo-Scandinavian Cardiac Outcomes Trial- Lipid-Lowering Arm (ASCOT-LLA). Circulation 110(Suppl III):III-402(abstract 1905)
-
-
-
-
30
-
-
0028813466
-
Hyperlipidaemia, hypertension, and coronary heart disease
-
Goode GK, Miller JP, Heagerty AM (1995) Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 345(8946):362-364
-
(1995)
Lancet
, vol.345
, Issue.8946
, pp. 362-364
-
-
Goode, G.K.1
Miller, J.P.2
Heagerty, A.M.3
-
31
-
-
0036867954
-
Lipid lowering: Another method of reducing blood pressure?
-
Wierzbicki AS (2002) Lipid lowering: Another method of reducing blood pressure? J Hum Hypertens 16(11):753-760
-
(2002)
J Hum Hypertens
, vol.16
, Issue.11
, pp. 753-760
-
-
Wierzbicki, A.S.1
-
32
-
-
33746218174
-
Statins and hypertension
-
Wierzbicki AS (2006) Statins and hypertension. J Hum Hypertens 20(8):551-553
-
(2006)
J Hum Hypertens
, vol.20
, Issue.8
, pp. 551-553
-
-
Wierzbicki, A.S.1
-
33
-
-
0028813466
-
Hyperlipidaemia, hypertension, and coronary heart disease
-
Goode GK, Miller JP, Heagerty AM (1995) Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 345:362-364
-
(1995)
Lancet
, vol.345
, pp. 362-364
-
-
Goode, G.K.1
Miller, J.P.2
Heagerty, A.M.3
-
34
-
-
33746257177
-
Effect of pravastatin on blood pressure in people with cardiovascular disease
-
Tonelli M, Sacks F, Pfeffer M, et al. (2006) Effect of pravastatin on blood pressure in people with cardiovascular disease. J Hum Hypertens 20(8):560-565
-
(2006)
J Hum Hypertens
, vol.20
, Issue.8
, pp. 560-565
-
-
Tonelli, M.1
Sacks, F.2
Pfeffer, M.3
-
36
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
-
Shepherd J, Blauw GJ, Murphy MB, et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 360(9346):1623-1630
-
(2002)
Lancet
, vol.360
, Issue.9346
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
-
37
-
-
0026582213
-
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
-
Watts GF, Lewis B, Brunt JN, et al. (1992) Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339(8793):563-569
-
(1992)
Lancet
, vol.339
, Issue.8793
, pp. 563-569
-
-
Watts, G.F.1
Lewis, B.2
Brunt, J.N.3
-
38
-
-
0035941990
-
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study, a randomised study
-
Diabetes Atherosclerosis Intervention Study Group
-
Diabetes Atherosclerosis Intervention Study Group (2001) Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 357(9260):905-910
-
(2001)
Lancet
, vol.357
, Issue.9260
, pp. 905-910
-
-
-
39
-
-
10044281651
-
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2. A double-blind, placebo-controlled study of extendedrelease niacin on atherosclerosis progression in secondary prevention patients treated with statins
-
Taylor AJ, Sullenberger LE, Lee HJ, et al. (2004) Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2. A double-blind, placebo-controlled study of extendedrelease niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 110(23):3512-3517
-
(2004)
Circulation
, vol.110
, Issue.23
, pp. 3512-3517
-
-
Taylor, A.J.1
Sullenberger, L.E.2
Lee, H.J.3
-
40
-
-
0036208934
-
Beyond LDL-C: The importance of raising HDL-C
-
Wierzbicki AS, Mikhailidis DP (2002) Beyond LDL-C: The importance of raising HDL-C. Curr Med Res Opin 18(1):36-44
-
(2002)
Curr Med Res Opin
, vol.18
, Issue.1
, pp. 36-44
-
-
Wierzbicki, A.S.1
Mikhailidis, D.P.2
-
41
-
-
4344665253
-
Raising highdensity lipoprotein cholesterol with reduction of cardiovascular risk: The role of nicotinic acid - A position paper developed by the European Consensus Panel on HDL-C
-
Chapman MJ, Assmann G, Fruchart JC, et al. (2004) Raising highdensity lipoprotein cholesterol with reduction of cardiovascular risk: The role of nicotinic acid - A position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 20(8):1253-1268
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.8
, pp. 1253-1268
-
-
Chapman, M.J.1
Assmann, G.2
Fruchart, J.C.3
-
43
-
-
2942564118
-
The nicotinic acid receptor: A new mechanism for an old drug
-
Karpe F, Frayn KN (2004) The nicotinic acid receptor: A new mechanism for an old drug. Lancet 363(9424):1892-1894
-
(2004)
Lancet
, vol.363
, Issue.9424
, pp. 1892-1894
-
-
Karpe, F.1
Frayn, K.N.2
-
44
-
-
19944426989
-
A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: Effects on progression of coronary heart disease and clinical events
-
Whitney EJ, Krasuski RA, Personius BE, et al. (2005) A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: Effects on progression of coronary heart disease and clinical events. Ann Intern Med 142(2):95-104
-
(2005)
Ann Intern Med
, vol.142
, Issue.2
, pp. 95-104
-
-
Whitney, E.J.1
Krasuski, R.A.2
Personius, B.E.3
-
45
-
-
0023001772
-
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
-
Canner PL, Berge KG, Wenger NK, et al. (1986) Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin. J Am Coll Cardiol 8(6):1245-1255
-
(1986)
J Am Coll Cardiol
, vol.8
, Issue.6
, pp. 1245-1255
-
-
Canner, P.L.1
Berge, K.G.2
Wenger, N.K.3
-
46
-
-
0033527030
-
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
-
Rubins HB, Robins SJ, Collins D, et al. (1999) Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 141(6):410-418
-
(1999)
N Engl J Med
, vol.141
, Issue.6
, pp. 410-418
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
-
47
-
-
0023232216
-
Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
Frick MH, Elo O, Haapa K, et al. (1987) Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317(20):1237-1245
-
(1987)
N Engl J Med
, vol.317
, Issue.20
, pp. 1237-1245
-
-
Frick, M.H.1
Elo, O.2
Haapa, K.3
-
48
-
-
0037099364
-
The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations
-
Sacks FM (2002) The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations. Am J Cardiol 90(2):139-143
-
(2002)
Am J Cardiol
, vol.90
, Issue.2
, pp. 139-143
-
-
Sacks, F.M.1
-
49
-
-
16344395132
-
Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
-
Wierzbicki AS (2005) Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?. Curr Med Res Opin 21(2):299-306
-
(2005)
Curr Med Res Opin
, vol.21
, Issue.2
, pp. 299-306
-
-
Wierzbicki, A.S.1
-
50
-
-
0342506477
-
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group
-
Frick MH, Syvanne M, Nieminen MS, et al. (1997) Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group. Circulation 96(7):2137-2143
-
(1997)
Circulation
, vol.96
, Issue.7
, pp. 2137-2143
-
-
Frick, M.H.1
Syvanne, M.2
Nieminen, M.S.3
-
51
-
-
0029982038
-
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
-
Ericsson CG, Hamsten A, Nilsson J, et al. (1996) Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 347(9005):849-853
-
(1996)
Lancet
, vol.347
, Issue.9005
, pp. 849-853
-
-
Ericsson, C.G.1
Hamsten, A.2
Nilsson, J.3
-
52
-
-
28044452217
-
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
-
Keech A, Simes RJ, Barter P, et al. (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet 366(9500):1849-1861
-
(2005)
Lancet
, vol.366
, Issue.9500
, pp. 1849-1861
-
-
Keech, A.1
Simes, R.J.2
Barter, P.3
-
53
-
-
33645086352
-
FIELDS of dreams, fields of tears: A perspective on the fibrate trials
-
Wierzbicki AS (2006) FIELDS of dreams, fields of tears: A perspective on the fibrate trials. Int J Clin Pract 60(4):442-449
-
(2006)
Int J Clin Pract
, vol.60
, Issue.4
, pp. 442-449
-
-
Wierzbicki, A.S.1
-
54
-
-
33746766313
-
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
-
Chapman MJ (2006) Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Pharmacol Ther 111(3):893-908
-
(2006)
Pharmacol Ther
, vol.111
, Issue.3
, pp. 893-908
-
-
Chapman, M.J.1
-
55
-
-
0242577955
-
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial
-
Nissen SE, Tsunoda T, Tuzcu EM, et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290(17):2292-2300
-
(2003)
JAMA
, vol.290
, Issue.17
, pp. 2292-2300
-
-
Nissen, S.E.1
Tsunoda, T.2
Tuzcu, E.M.3
-
56
-
-
7744243517
-
Lipid-altering agents: The future
-
Wierzbicki AS (2004) Lipid-altering agents: the future. Int J Clin Pract 58(11):1063-1072
-
(2004)
Int J Clin Pract
, vol.58
, Issue.11
, pp. 1063-1072
-
-
Wierzbicki, A.S.1
-
57
-
-
31644445200
-
Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease
-
Barter PJ, Kastelein JJ (2006) Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. J Am Coll Cardiol 47(3):492-499
-
(2006)
J Am Coll Cardiol
, vol.47
, Issue.3
, pp. 492-499
-
-
Barter, P.J.1
Kastelein, J.J.2
-
58
-
-
26444544458
-
Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients
-
Kennedy J, Quan H, Buchan AM, et al. (2005) Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36(10):2072-2076
-
(2005)
Stroke
, vol.36
, Issue.10
, pp. 2072-2076
-
-
Kennedy, J.1
Quan, H.2
Buchan, A.M.3
-
59
-
-
23744504398
-
Three-year follow-up results of angiographic intervention trial using an HMG-CoA reductase inhibitor to evaluate retardation of obstructive multiple atheroma (ATHEROMA) study
-
Yokoi H, Nobuyoshi M, Mitsudo K, et al. (2005) Three-year follow-up results of angiographic intervention trial using an HMG-CoA reductase inhibitor to evaluate retardation of obstructive multiple atheroma (ATHEROMA) study. Circ J 69(8):875-883
-
(2005)
Circ J
, vol.69
, Issue.8
, pp. 875-883
-
-
Yokoi, H.1
Nobuyoshi, M.2
Mitsudo, K.3
-
60
-
-
0031829175
-
The lipoprotein and coronary atherosclerosis study (LCAS): Lipid and metabolic factors related to atheroma and clinical events
-
Herd JA (1998) The lipoprotein and coronary atherosclerosis study (LCAS): Lipid and metabolic factors related to atheroma and clinical events. Am J Med 104(6A):42S-49S
-
(1998)
Am J Med 104(6A)
-
-
Herd, J.A.1
-
61
-
-
0027981582
-
Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS)
-
Multicenter Anti-Atheroma Study Investigators
-
Multicenter Anti-Atheroma Study Investigators (1994) Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 344(8923):633-638
-
(1994)
Lancet
, vol.344
, Issue.8923
, pp. 633-638
-
-
-
62
-
-
0027488722
-
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS)
-
Blankenhorn DH, Azen SP, Kramsch DM, et al. (1993) Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1119(10):969-976
-
(1993)
Ann Intern Med
, vol.1119
, Issue.10
, pp. 969-976
-
-
Blankenhorn, D.H.1
Azen, S.P.2
Kramsch, D.M.3
-
63
-
-
0028849703
-
Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events. PLAC I investigation
-
Pitt B, Mancini GB, Ellis SG, et al. (1995) Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events. PLAC I investigation. J Am Coll Cardiol 26(5):1133-1139
-
(1995)
J Am Coll Cardiol
, vol.26
, Issue.5
, pp. 1133-1139
-
-
Pitt, B.1
Mancini, G.B.2
Ellis, S.G.3
-
64
-
-
0029050796
-
Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)
-
Jukema JW, Bruschke AV, van Boven AJ, et al. (1995) Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91(10):2528-2540
-
(1995)
Circulation
, vol.91
, Issue.10
, pp. 2528-2540
-
-
Jukema, J.W.1
Bruschke, A.V.2
van Boven, A.J.3
-
65
-
-
7744231805
-
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized controlled trial
-
Nissen SE, Tuzcu EM, Libby P, et al. (2004) Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized controlled trial. JAMA 292(18):2217-2225
-
(2004)
JAMA
, vol.292
, Issue.18
, pp. 2217-2225
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Libby, P.3
-
66
-
-
33645097996
-
Effect of ACAT inhibition on the progression of coronary atherosclerosis
-
Nissen SE, Tuzcu EM, Brewer HB, et al. (2006) Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 354(12):1253-1263
-
(2006)
N Engl J Med
, vol.354
, Issue.12
, pp. 1253-1263
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Brewer, H.B.3
-
67
-
-
20844449696
-
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions
-
Tardif JC, Gregoire J, L'Allier PL, et al. (2004) Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110(21):3372-3377
-
(2004)
Circulation
, vol.110
, Issue.21
, pp. 3372-3377
-
-
Tardif, J.C.1
Gregoire, J.2
L'Allier, P.L.3
|